POSTER SESSION IV
Tuesday, March 1, 2011   —  1:00 PM - 4:30 PM
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




GASTROINTESTINAL



Poster#Title and AuthorsItinerary
Planner
57 Caveat Emptor: CD10 Is Not a Reliable Marker of Inflamed Small Intestine. (664)
JM Lloyd, SR Owens - UPMC, Pittsburgh, PA
Add
58 Crypt Apoptotic Count Reproducibility in Small Bowel Allograft Biopsies. (709)
G Talmon, R El Behery, S Radio, J Wisecarver, V Shostrom - University of Nebraska Medical Center, Omaha
Add
59 Duodenal Intraepithelial Lymphocytosis in Helicobacter pylori Gastritis: A Comparison after Treatment. (663)
KA Lloyd, MM Yeh - University of Washington, Seattle
Add
60 Duodenal Serrated Adenomas: Evidence for Serrated Carcinogenesis in the Proximal Small Intestine. (705)
A Srivastava, TA Rege, KM Kim, JA Lefferts, CK Park, GJ Tsongalis, RD Odze - Dartmouth Hitchcock Medical Center, Lebanon, NH; Brigham & Women's Hospital, Boston, MA; Samsung Medical Center, Seoul, Korea
Add
61 Duodenal Adenomas: Clinical, Endoscopic, and Histopathologic Characteristics in 1,132 Patients. (643)
JM Hurrell, RM Genta - Caris Life Sciences, Irving, TX; UT Southwestern and Dallas VA Medical Center, TX
Add
62 Epithelial Changes Indefinite for Dysplasia in the Pouch and Peri-Pouch but Not Rectal Cuff Is Associated with Inflammation and Warrants Close Follow-Up. (662)
X Liu, B Shen, D Patil - Cleveland Clinic
Add
63 Biomarkers of Cancer Risk in Ulcerative Colitis (UC) Pouches Post Colectomy: A Pilot Study. (647)
W Jiang, AE Bennett, ML Settle, MP Bronner - Cleveland Clinic, OH
Add
64 Heterogeneity in Signaling Pathways of Gastrointestinal Neuroendocrine Cell Tumors: A Critical Look at Notch Signaling Pathway. (721)
H Wang, Y Chen, V Deshpande - Massachusetts General Hospital/Harvard Medical School, Boston; Delaware University, Newark, DE
Add
65 An Objective Assessment of Ki67 Proliferative Index Quantification in Gastroenteropancreatic Neuroendocrine Tumors (NETs). (712)
LH Tang, M Gonen, C Hedvat, IM Modlin, DS Klimstra - Memorial Sloan-Kettering Cancer Center, New York, NY; Yale University, School of Medicine, New Haven, CT
Add
66 Gain of Expression of Aldo-Ketoreductase Family 1 B10 (AKR1B10) Protein in Pancreatic Adenocarcinoma: A Potential Therapeutic Target. (667)
KA Matkowskyj, J Liao, HN Li, X Ding, MS Rao, G-Y Yang - Northwestern University, Chicago, IL
Add
67 PTEN Loss of Heterozygosity Correlates with Decreased PTEN Expression and Increased p53 Expression in Intraductal Papillary Mucinous Neoplasms of the Pancreas. (715)
AT Turk, D Garcia-Carracedo, BC Tweel, GH Su, JA Chabot, HE Remotti - Columbia University, New York, NY
Add
68 Gastrin-Releasing Peptide Receptor Pathway Immunoexpression Profile in Pancreatic Endocrine Tumors. (668)
T McDonald, JM Lloyd, D Hartman, AM Krasinskas, RR Seethala - UPMC, Pittsburgh, PA
Add
69 Osteoclastic Giant Cell Tumor of the Pancreas: Clinicopathological Correlation Study of Twelve Cases. (711)
D Tan, W Payne, T Khoury, W Li, NA Bhadkamkar, MM Javle - University of Texas M.D. Anderson Cancer Center, Houston
Add
70 Metaplasia in the Gallbladder: An Analysis of Clinicopathologic Associations in 1218 Cholecystectomies. (618)
N Dursun, JC Roa, O Tapia, O Basturk, S Bandyopadhyay, A Cakir, M Goodman, J Sarmiento, H Losada, N Adsay - Emory, GA; UFRO, Temuco, Chile; MSKCC, NY; WSU, MI
Add
71 Mucosal Predominant Lymphoplasmacytic Inflammation May Be Associated with but Is Not Specific for Autoimmune and Distal Obstructive Biliary Pathology: An Analysis of 998 Cholecystectomies and Proposal for Diffuse Chronic Superficial Cholecystitis as the Category Designation. (696)
B Saka, N Dursun, O Basturk, L Ducato, P Bagci, O Tapia, JC Roa, S Bandyopadhyay, N Adsay - Emory, GA; MSKCC, NY; UFRO, Temuco, Chile; WSU, MI
Add
72 Usefulness of Maspin Immunostaining in Distinguishing Adenocarcinoma from Benign Epithelium in Endoscopic Bile Duct Biopsies. (637)
EA Himmelfarb, F Lin, HL Wang - Cedars-Sinai Medical Center, Los Angeles, CA; Geisinger Medical Center, Danville, PA
Add
73 The Diagnostic Utility of Hepatocyte Antigen, GPC3, and IMP3 in Distinguishing between Hepatocellular Carcinoma and Benign Hepatic Lesions. (702)
F Siadat, BN Nguyen, M Gomes, EC Marginean - University of Ottawa, ON, Canada
Add
74 IMP3, an Oncofetal Protein, Is a Useful Diagnostic Biomarker for Hepatocellular Carcinoma. (651)
M Kamionek, Z Jiang, P Chu, K Rock, D Kandil - UMass Memorial Medical Center, Worcester, MA; City of Hope National Medical Center, Duarte, CA
Add